Insider transactions

EDGAR

Rapport Therapeutics, Inc.

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.

A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.

Window: transactions dated on or after 2025-11-19.

Open-market purchases (code P)
11 transactions, 1,031,174 shares
Sum of shares × price per share: 22,023,904.3417
Open-market sales (code S)
66 transactions, 1,166,718 shares
Sum of shares × price per share: 46,732,178.4376

Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.

Showing 1–50 of 99

Insider transactions, newest first, as filed on SEC Forms 3, 4 and 5
DateReporting ownerCodeAcquired or disposedSharesPrice per share, as filedValue (derived)Shares owned afterDirect or indirectRule 10b5-1 boxNotesSource
2026-10-30 Filed 2026-11-03Third Rock Ventures V, L.P. Director · 10% ownerThird Rock Ventures GP V, LP Director · 10% ownerTRV GP V, LLC Director · 10% ownerThird Rock Ventures VI, L.P. Director · 10% ownerThird Rock Ventures GP VI, L.P. Director · 10% ownerTRV GP VI, LLC Director · 10% owner
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)238,09521
4,999,995

Derived: shares × price per share. Exact value 4999995.

6,518,620Direct (D) No
F1, F2, F3
  • F1 Shares acquired in a private placement pursuant to a Securities Purchase Agreement dated October 28, 2026 by and between the Issuer, Third Rock Ventures V, L.P. (TRV V) and Third Rock Ventures VI, L.P. (TRV VI).
  • F2 These shares are directly held by TRV V. The general partner of TRV V is Third Rock Ventures GP V, L.P. (TRV GP V). The general partner of TRV GP V is TRV GP V, LLC (TRV GP V LLC). Each of TRV GP V and TRV GP V LLC disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that it is the beneficial owner of such shares.
  • F3 Each of Reporting Persons disclaims the existence of a Section 13(d) group as between any TRV V related parties and any TRV VI related parties and this report shall not be deemed an admission that any of such parties is or may be part of such a group with any of the other parties.
Open filing 0001193125-26-445438 Read from the filing’s XML Dispute this row
2026-10-30 Filed 2026-11-03Third Rock Ventures V, L.P. Director · 10% ownerThird Rock Ventures GP V, LP Director · 10% ownerTRV GP V, LLC Director · 10% ownerThird Rock Ventures VI, L.P. Director · 10% ownerThird Rock Ventures GP VI, L.P. Director · 10% ownerTRV GP VI, LLC Director · 10% owner
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)1,190,47621
24,999,996

Derived: shares × price per share. Exact value 24999996.

2,159,694Indirect (I) By Third Rock Ventures VI, L.P.No
F1, F3, F4
  • F1 Shares acquired in a private placement pursuant to a Securities Purchase Agreement dated October 28, 2026 by and between the Issuer, Third Rock Ventures V, L.P. (TRV V) and Third Rock Ventures VI, L.P. (TRV VI).
  • F3 Each of Reporting Persons disclaims the existence of a Section 13(d) group as between any TRV V related parties and any TRV VI related parties and this report shall not be deemed an admission that any of such parties is or may be part of such a group with any of the other parties.
  • F4 These shares are held directly by TRV VI. The general partner of TRV VI is Third Rock Ventures GP VI, L.P. (TRV GP VI). The general partner of TRV GP VI is TRV GP VI, LLC (TRV GP VI LLC). Each of TRV GP VI, and TRV GP VI LLC, disclaims beneficial ownership of these shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that it is the beneficial owner of such shares.
Open filing 0001193125-26-445438 Read from the filing’s XML Dispute this row
2026-10-28 Filed 2026-10-30HEALY JAMES Director
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)952,38021.00
19,999,980

Derived: shares × price per share. Exact value 19999980.00.

2,815,707Indirect (I) By Sofinnova Venture Partners XI, L.P.No
F1
  • F1 The shares are directly held by Sofinnova Venture Partners XI, L.P. (SVP XI). Sofinnova Management XI, L.P. (SM XI LP) is the general partner of SVP XI and Sofinnova Management XI, L.L.C. (SM XI) is the general partner of SM XI LP. The Reporting Person is a managing member of SM XI and may be deemed to share voting and dispositive power over the shares held by SVP XI. The Reporting Person disclaims beneficial ownership of such shares for purposes of Section 16 of the Exchange Act, except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that he is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose.
Open filing 0001104659-26-120789 Read from the filing’s XML Dispute this row
2026-10-28 Filed 2026-10-30HEALY JAMES Director
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)6,39521.00
134,295

Derived: shares × price per share. Exact value 134295.00.

17,990Indirect (I) By SummitTX Master, SPC -SummitTX Apex SP - Healthcare 3No
F2
  • F2 The shares are directly held by SummitTX Master, SPC - SummitTX Apex SP - Healthcare 3 (f/k/a Crestline Summit Master, SPC - Crestline Summit Apex SP) (Apex SP). Sofinnova BioEquities GP LLC (BioEquities GP) is the general partner of Apex SP. The Reporting Person is a managing member of BioEquities GP and may be deemed to share voting and dispositive power over the shares held by Apex SP. The Reporting Person disclaims beneficial ownership of such shares for purposes of Section 16 of the Exchange Act, except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that he is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose.
Open filing 0001104659-26-120789 Read from the filing’s XML Dispute this row
2026-10-28 Filed 2026-10-30HEALY JAMES Director
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)3,77221.00
79,212

Derived: shares × price per share. Exact value 79212.00.

14,924Indirect (I) By SummitTX Master, SPC - SummitTX Alpha SP - Healthcare 3No
F3
  • F3 The shares are directly held by SummitTX Master, SPC - SummitTX Alpha SP - Healthcare 3 (f/k/a Crestline Summit Master, SPC - PEAK SP) (Alpha SP). BioEquities GP is the general partner of Alpha SP. The Reporting Person is a managing member of BioEquities GP and may be deemed to share voting and dispositive power over the shares held by Alpha SP. The Reporting Person disclaims beneficial ownership of such shares for purposes of Section 16 of the Exchange Act, except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that he is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose.
Open filing 0001104659-26-120789 Read from the filing’s XML Dispute this row
2026-10-28 Filed 2026-10-30HEALY JAMES Director
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)6,93321.00
145,593

Derived: shares × price per share. Exact value 145593.00.

25,267Indirect (I) By SummitTX Pinnacle Master, L.P. - Healthcare 3No
F4
  • F4 The shares are directly held by SummitTX Pinnacle Master, L.P. - Healthcare 3 (f/k/a Crestline Summit Pinnacle Master, L.P.) (Pinnacle LP). BioEquities GP is the general partner of Pinnacle LP. The Reporting Person is a managing member of BioEquities GP and may be deemed to share voting and dispositive power over the shares held by Pinnacle LP. The Reporting Person disclaims beneficial ownership of such shares for purposes of Section 16 of the Exchange Act, except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that he is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose.
Open filing 0001104659-26-120789 Read from the filing’s XML Dispute this row
2026-10-23 Filed 2026-10-23Sanchez Ramiro Director
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)3,60027.3549
98,477.64

Derived: shares × price per share. Exact value 98477.6400.

3,600Direct (D) No
F1
  • F1 The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $27.07 to $27.47, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price at which the transactions were effected.
Open filing 0001193125-26-430397 Read from the filing’s XML Dispute this row
2026-10-22 Filed 2026-10-22PAUL STEVEN M Director
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)35,71427.28
974,277.92

Derived: shares × price per share. Exact value 974277.92.

77,380Indirect (I) By Paul Capital Strategy III Fund LLCNo
F1, F2
  • F1 The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $26.87 to $27.84, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price at which the transactions were effected.
  • F2 Shares held by Paul Capital Strategy III Fund LLC. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any.
Open filing 0001193125-26-429073 Read from the filing’s XML Dispute this row
2026-10-22 Filed 2026-10-22Silva Paul M Director
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)3,68027.075
99,636

Derived: shares × price per share. Exact value 99636.000.

3,680Indirect (I) By Paul M Silva 2016 Declaration of Trust U/A DTD 12/19/2016No— Open filing 0001193125-26-429075 Read from the filing’s XML Dispute this row
2026-10-22 Filed 2026-10-22MARAGANORE JOHN Director
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)8,23926.3799
217,343.9961

Derived: shares × price per share. Exact value 217343.9961.

8,239Indirect (I) By John M. Maraganore Revocable TrustNo
F1
  • F1 The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $25.81 to $26.73, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price at which the transactions were effected.
Open filing 0001193125-26-429071 Read from the filing’s XML Dispute this row
2026-10-22 Filed 2026-10-22MARAGANORE JOHN Director
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)1,17226.9173
31,547.0756

Derived: shares × price per share. Exact value 31547.0756.

9,411Indirect (I) By John M. Maraganore Revocable TrustNo
F2
  • F2 The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $26.81 to $26.98 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price at which the transactions were effected.
Open filing 0001193125-26-429071 Read from the filing’s XML Dispute this row
2026-10-22 Filed 2026-10-22Young Wendy B. Director
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)3,78926.39
99,991.71

Derived: shares × price per share. Exact value 99991.71.

13,289Direct (D) No— Open filing 0001193125-26-429074 Read from the filing’s XML Dispute this row
2026-10-21 Filed 2026-10-23Ceesay Abraham Director · Officer: Chief Executive Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)2,21029.1618
64,447.578

Derived: shares × price per share. Exact value 64447.5780.

450,035Direct (D) Yes
F1, F2
  • F1 These transactions were effected by the Reporting Person pursuant to Rule 10b5-1 trading plans adopted on March 27, 2026.
  • F2 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $28.89 to $29.55, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
Open filing 0001193125-26-430504 Read from the filing’s XML Dispute this row
2026-10-21 Filed 2026-10-21Ignelzi Troy A. Officer: Chief Financial Officer
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)5,50026.10
143,550

Derived: shares × price per share. Exact value 143550.00.

15,500Direct (D) No— Open filing 0001193125-26-428018 Read from the filing’s XML Dispute this row
2026-10-07 Filed 2026-10-08Ceesay Abraham Director · Officer: Chief Executive Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)1,14730.6600
35,167.02

Derived: shares × price per share. Exact value 35167.0200.

452,245Direct (D) Yes
F1, F3
  • F1 These transactions were effected by the Reporting Person pursuant to Rule 10b5-1 trading plans adopted on March 27, 2026.
  • F3 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.33 to $30.89, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
Open filing 0001193125-26-417919 Read from the filing’s XML Dispute this row
2026-10-06 Filed 2026-10-08Ceesay Abraham Director · Officer: Chief Executive Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)3,37532.0314
108,105.975

Derived: shares × price per share. Exact value 108105.9750.

453,392Direct (D) Yes
F1, F2
  • F1 These transactions were effected by the Reporting Person pursuant to Rule 10b5-1 trading plans adopted on March 27, 2026.
  • F2 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $31.65 to $32.64, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
Open filing 0001193125-26-417919 Read from the filing’s XML Dispute this row
2026-09-30 Filed 2026-10-01Gault Cheryl Officer: Chief Operating Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)7,92533.0364
261,813.47

Derived: shares × price per share. Exact value 261813.4700.

141,989Direct (D) Yes
F1, F2
  • F1 These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on December 10, 2025.
  • F2 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $32.64 to $33.62, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
Open filing 0001193125-26-410734 Read from the filing’s XML Dispute this row
2026-09-30 Filed 2026-10-01Gault Cheryl Officer: Chief Operating Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)2,07533.7556
70,042.87

Derived: shares × price per share. Exact value 70042.8700.

139,914Direct (D) Yes
F1, F3
  • F1 These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on December 10, 2025.
  • F3 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $33.64 to $34.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
Open filing 0001193125-26-410734 Read from the filing’s XML Dispute this row
2026-09-23 Filed 2026-09-24Ceesay Abraham Director · Officer: Chief Executive Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)1,95239.0523
76,230.0896

Derived: shares × price per share. Exact value 76230.0896.

457,025Direct (D) Yes
F1, F2
  • F1 These transactions were effected by the Reporting Person pursuant to Rule 10b5-1 trading plans adopted on March 27, 2026.
  • F2 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $38.54 to $39.48, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
Open filing 0001193125-26-401017 Read from the filing’s XML Dispute this row
2026-09-23 Filed 2026-09-24Ceesay Abraham Director · Officer: Chief Executive Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)21539.8602
8,569.943

Derived: shares × price per share. Exact value 8569.9430.

456,810Direct (D) Yes
F1, F3
  • F1 These transactions were effected by the Reporting Person pursuant to Rule 10b5-1 trading plans adopted on March 27, 2026.
  • F3 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $39.57 to $40.25, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
Open filing 0001193125-26-401017 Read from the filing’s XML Dispute this row
2026-09-23 Filed 2026-09-24Ceesay Abraham Director · Officer: Chief Executive Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)4341.05
1,765.15

Derived: shares × price per share. Exact value 1765.15.

456,767Direct (D) Yes
F1
  • F1 These transactions were effected by the Reporting Person pursuant to Rule 10b5-1 trading plans adopted on March 27, 2026.
Open filing 0001193125-26-401017 Read from the filing’s XML Dispute this row
2026-09-08 Filed 2026-09-09Ceesay Abraham Director · Officer: Chief Executive Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)7,14145.5550
325,308.255

Derived: shares × price per share. Exact value 325308.2550.

460,046Direct (D) Yes
F1, F2
  • F1 These transactions were effected by the Reporting Person pursuant to Rule 10b5-1 trading plans adopted on March 27, 2026.
  • F2 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $44.94 to $45.90, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
Open filing 0001193125-26-386436 Read from the filing’s XML Dispute this row
2026-09-08 Filed 2026-09-09Ceesay Abraham Director · Officer: Chief Executive Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)1,06946.0147
49,189.7143

Derived: shares × price per share. Exact value 49189.7143.

458,977Direct (D) Yes
F1, F3
  • F1 These transactions were effected by the Reporting Person pursuant to Rule 10b5-1 trading plans adopted on March 27, 2026.
  • F3 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.95 to $46.17, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
Open filing 0001193125-26-386436 Read from the filing’s XML Dispute this row
2026-08-25 Filed 2026-08-26Yeleswaram Krishnaswamy Officer: Chief Development Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)20,79950.3111
1,046,420.5689

Derived: shares × price per share. Exact value 1046420.5689.

212,063Direct (D) Yes
F1, F3
  • F1 These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on December 10, 2025.
  • F3 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $49.90 to $50.88 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
Open filing 0001193125-26-368244 Read from the filing’s XML Dispute this row
2026-08-25 Filed 2026-08-26Yeleswaram Krishnaswamy Officer: Chief Development Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)16,20151.0576
827,184.1776

Derived: shares × price per share. Exact value 827184.1776.

195,862Direct (D) Yes
F1, F4
  • F1 These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on December 10, 2025.
  • F4 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $50.91 to $51.39 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
Open filing 0001193125-26-368244 Read from the filing’s XML Dispute this row
2026-08-25 Filed 2026-08-26Ceesay Abraham Director · Officer: Chief Executive Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)18,92149.5723
937,957.4883

Derived: shares × price per share. Exact value 937957.4883.

467,187Direct (D) Yes
F1, F2
  • F1 These transactions were effected by the Reporting Person pursuant to Rule 10b5-1 trading plans adopted on March 27, 2026.
  • F2 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $49.03 to $50.03, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
Open filing 0001193125-26-368285 Read from the filing’s XML Dispute this row
2026-08-24 Filed 2026-08-26Yeleswaram Krishnaswamy Officer: Chief Development Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)13,16049.9983
657,977.628

Derived: shares × price per share. Exact value 657977.6280.

232,862Direct (D) Yes
F1, F2
  • F1 These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on December 10, 2025.
  • F2 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $49.90 to $50.25 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
Open filing 0001193125-26-368244 Read from the filing’s XML Dispute this row
2026-08-19 Filed 2026-08-20Yeleswaram Krishnaswamy Officer: Chief Development Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)40449.90
20,159.6

Derived: shares × price per share. Exact value 20159.60.

246,022Direct (D) Yes
F1
  • F1 These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on December 10, 2025.
Open filing 0001193125-26-359189 Read from the filing’s XML Dispute this row
2026-08-11 Filed 2026-08-12Ceesay Abraham Director · Officer: Chief Executive Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)3,66446.8988
171,837.2032

Derived: shares × price per share. Exact value 171837.2032.

511,402Direct (D) Yes
F1, F4
  • F1 These transactions were effected by the Reporting Person pursuant to Rule 10b5-1 trading plans adopted on March 27, 2026.
  • F4 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $46.32 to $47.29, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
Open filing 0001193125-26-346995 Read from the filing’s XML Dispute this row
2026-08-11 Filed 2026-08-12Ceesay Abraham Director · Officer: Chief Executive Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)19,50048.0434
936,846.3

Derived: shares × price per share. Exact value 936846.3000.

491,902Direct (D) Yes
F1, F5
  • F1 These transactions were effected by the Reporting Person pursuant to Rule 10b5-1 trading plans adopted on March 27, 2026.
  • F5 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $47.45 to $48.43, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
Open filing 0001193125-26-346995 Read from the filing’s XML Dispute this row
2026-08-11 Filed 2026-08-12Ceesay Abraham Director · Officer: Chief Executive Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)5,79448.6229
281,721.0826

Derived: shares × price per share. Exact value 281721.0826.

486,108Direct (D) Yes
F1, F6
  • F1 These transactions were effected by the Reporting Person pursuant to Rule 10b5-1 trading plans adopted on March 27, 2026.
  • F6 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $48.45 to $48.87, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
Open filing 0001193125-26-346995 Read from the filing’s XML Dispute this row
2026-08-10 Filed 2026-08-12Ceesay Abraham Director · Officer: Chief Executive Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)14,17145.9736
651,491.8856

Derived: shares × price per share. Exact value 651491.8856.

523,436Direct (D) Yes
F1, F2
  • F1 These transactions were effected by the Reporting Person pursuant to Rule 10b5-1 trading plans adopted on March 27, 2026.
  • F2 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.37 to $46.36, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
Open filing 0001193125-26-346995 Read from the filing’s XML Dispute this row
2026-08-10 Filed 2026-08-12Ceesay Abraham Director · Officer: Chief Executive Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)8,37046.7479
391,279.923

Derived: shares × price per share. Exact value 391279.9230.

515,066Direct (D) Yes
F1, F3
  • F1 These transactions were effected by the Reporting Person pursuant to Rule 10b5-1 trading plans adopted on March 27, 2026.
  • F3 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $46.38 to $47.01, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
Open filing 0001193125-26-346995 Read from the filing’s XML Dispute this row
2026-07-27 Filed 2026-07-29Ceesay Abraham Director · Officer: Chief Executive Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)2,20342.1070
92,761.721

Derived: shares × price per share. Exact value 92761.7210.

537,614Direct (D) Yes
F1, F2
  • F1 These transactions were effected by the Reporting Person pursuant to Rule 10b5-1 trading plans adopted on March 27, 2026.
  • F2 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $41.66 to $42.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
Open filing 0001193125-26-323637 Read from the filing’s XML Dispute this row
2026-07-27 Filed 2026-07-29Ceesay Abraham Director · Officer: Chief Executive Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)742.7350
299.145

Derived: shares × price per share. Exact value 299.1450.

537,607Direct (D) Yes
F1
  • F1 These transactions were effected by the Reporting Person pursuant to Rule 10b5-1 trading plans adopted on March 27, 2026.
Open filing 0001193125-26-323637 Read from the filing’s XML Dispute this row
2026-07-14 Filed 2026-07-15Ceesay Abraham Director · Officer: Chief Executive Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)5,48139.7217
217,714.6377

Derived: shares × price per share. Exact value 217714.6377.

542,546Direct (D) Yes
F1, F2
  • F1 These transactions were effected by the Reporting Person pursuant to Rule 10b5-1 trading plans adopted on March 27, 2026.
  • F2 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $39.36 to $40.35, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
Open filing 0001193125-26-304786 Read from the filing’s XML Dispute this row
2026-07-14 Filed 2026-07-15Ceesay Abraham Director · Officer: Chief Executive Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)2,72940.5724
110,722.0796

Derived: shares × price per share. Exact value 110722.0796.

539,817Direct (D) Yes
F1, F3
  • F1 These transactions were effected by the Reporting Person pursuant to Rule 10b5-1 trading plans adopted on March 27, 2026.
  • F3 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $40.37 to $40.73, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
Open filing 0001193125-26-304786 Read from the filing’s XML Dispute this row
2026-06-30 Filed 2026-07-01Gault Cheryl Officer: Chief Operating Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)1,90040.0914
76,173.66

Derived: shares × price per share. Exact value 76173.6600.

158,014Direct (D) Yes
F1, F2
  • F1 These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on December 10, 2025.
  • F2 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $39.61 to $40.58, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
Open filing 0001193125-26-292546 Read from the filing’s XML Dispute this row
2026-06-30 Filed 2026-07-01Gault Cheryl Officer: Chief Operating Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)3,79241.3934
156,963.7728

Derived: shares × price per share. Exact value 156963.7728.

154,222Direct (D) Yes
F1, F3
  • F1 These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on December 10, 2025.
  • F3 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $40.80 to $41.79, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
Open filing 0001193125-26-292546 Read from the filing’s XML Dispute this row
2026-06-30 Filed 2026-07-01Gault Cheryl Officer: Chief Operating Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)3,30842.1722
139,505.6376

Derived: shares × price per share. Exact value 139505.6376.

150,914Direct (D) Yes
F1, F4
  • F1 These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on December 10, 2025.
  • F4 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $41.81 to $42.75, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
Open filing 0001193125-26-292546 Read from the filing’s XML Dispute this row
2026-06-30 Filed 2026-07-01Gault Cheryl Officer: Chief Operating Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)1,00043.1547
43,154.7

Derived: shares × price per share. Exact value 43154.7000.

149,914Direct (D) Yes
F1, F5
  • F1 These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on December 10, 2025.
  • F5 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $42.81 to $43.65, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
Open filing 0001193125-26-292546 Read from the filing’s XML Dispute this row
2026-06-29 Filed 2026-07-01Ceesay Abraham Director · Officer: Chief Executive Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)7,34439.7688
292,062.0672

Derived: shares × price per share. Exact value 292062.0672.

548,903Direct (D) Yes
F1, F2
  • F1 These transactions were effected by the Reporting Person pursuant to Rule 10b5-1 trading plans adopted on March 27, 2026.
  • F2 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $39.25 to $40.225, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
Open filing 0001193125-26-292519 Read from the filing’s XML Dispute this row
2026-06-29 Filed 2026-07-01Ceesay Abraham Director · Officer: Chief Executive Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)87640.3375
35,335.65

Derived: shares × price per share. Exact value 35335.6500.

548,027Direct (D) Yes
F1, F3
  • F1 These transactions were effected by the Reporting Person pursuant to Rule 10b5-1 trading plans adopted on March 27, 2026.
  • F3 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $40.26 to $40.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
Open filing 0001193125-26-292519 Read from the filing’s XML Dispute this row
2026-06-10 Filed 2026-06-10MARAGANORE JOHN Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (15,200) — exercise price 35.21
Acquired (A)15,2000—15,200Direct (D) No
F1
  • F1 The shares underlying this option shall vest upon the earlier of (i) June 10, 2027 and (ii) the date of the next Annual Meeting of Stockholders of the Issuer, subject to the Reporting Person's continued service on such vesting date.
Open filing 0001193125-26-266155 Read from the filing’s XML Dispute this row
2026-06-10 Filed 2026-06-10Silva Paul M Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (15,200) — exercise price 35.21
Acquired (A)15,2000—15,200Direct (D) No
F1
  • F1 The shares underlying this option shall vest upon the earlier of (i) June 10, 2027 and (ii) the date of the next Annual Meeting of Stockholders of the Issuer, subject to the Reporting Person's continued service on such vesting date.
Open filing 0001193125-26-266099 Read from the filing’s XML Dispute this row
2026-06-10 Filed 2026-06-10Young Wendy B. Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (15,200) — exercise price 35.21
Acquired (A)15,2000—15,200Direct (D) No
F1
  • F1 The shares underlying this option shall vest upon the earlier of (i) June 10, 2027 and (ii) the date of the next Annual Meeting of Stockholders of the Issuer, subject to the Reporting Person's continued service on such vesting date.
Open filing 0001193125-26-266086 Read from the filing’s XML Dispute this row
2026-06-10 Filed 2026-06-10Sanchez Ramiro Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (15,200) — exercise price 35.21
Acquired (A)15,2000—15,200Direct (D) No
F1
  • F1 The shares underlying this option shall vest upon the earlier of (i) June 10, 2027 and (ii) the date of the next Annual Meeting of Stockholders of the Issuer, subject to the Reporting Person's continued service on such vesting date.
Open filing 0001193125-26-266080 Read from the filing’s XML Dispute this row
2026-06-10 Filed 2026-06-10Huber Reid M Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (15,200) — exercise price 35.21
Acquired (A)15,2000—15,200Direct (D) No
F1
  • F1 The shares underlying this option shall vest upon the earlier of (i) June 10, 2027 and (ii) the date of the next Annual Meeting of Stockholders of the Issuer, subject to the Reporting Person's continued service on such vesting date.
Open filing 0001193125-26-266090 Read from the filing’s XML Dispute this row
2026-06-10 Filed 2026-06-10HEALY JAMES Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (15,200) — exercise price 35.21
Acquired (A)15,2000—15,200Direct (D) No
F1
  • F1 The shares underlying this option shall vest upon the earlier of (i) June 10, 2027 and (ii) the date of the next Annual Meeting of Stockholders of the Issuer, subject to the Reporting Person's continued service on such vesting date.
Open filing 0001193125-26-266095 Read from the filing’s XML Dispute this row
2026-06-10 Filed 2026-06-10PEREZ ROBERT J Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (15,200) — exercise price 35.21
Acquired (A)15,2000—15,200Direct (D) No
F1
  • F1 The shares underlying this option shall vest upon the earlier of (i) June 10, 2027 and (ii) the date of the next Annual Meeting of Stockholders of the Issuer, subject to the Reporting Person's continued service on such vesting date.
Open filing 0001193125-26-266147 Read from the filing’s XML Dispute this row

Institutional holders (Form 13F)

Quarter ending 2026-09-30: 8,905 filings read, the latest filed 2026-11-18. Prior quarter ending 2026-06-30: 9,170 filings read.

Showing 1–50 of 184

Institutional holders, largest position first, as filed
ManagerShares or principalValue as filedChange from the prior quarterSource
FMR LLC Partly reported under another manager7,196,657 SH241,807,675 dollarsHigher by 23,763 Prior quarter: 7,172,894Open filing 0000315066-26-002964 Filed 2026-11-10 Dispute this row
TRV GP V, LLC 6,280,525 SH211,025,640 dollarsUnchanged Prior quarter: 6,280,525Open filing 0001193125-26-463550 Filed 2026-11-16 Dispute this row
ARCH Venture Management, LLC 3,728,738 SH125,285,597 dollarsUnchanged Prior quarter: 3,728,738Open filing 0001012975-26-001080 Filed 2026-11-16 Dispute this row
GOLDMAN SACHS GROUP INC Partly reported under another manager2,973,796 SH99,919,545 dollarsHigher by 63,347 Prior quarter: 2,910,449Open filing 0000886982-26-000647 Filed 2026-11-16 Dispute this row
BlackRock, Inc. Partly reported under another manager2,881,264 SH96,810,470 dollarsHigher by 181,478 Prior quarter: 2,699,786Open filing 0002012383-26-003985 Filed 2026-11-13 Dispute this row
Capital International Investors Partly reported under another manager2,653,640 SH89,162,304 dollarsLower by 268,318 Prior quarter: 2,921,958Open filing 0001562230-26-000136 Filed 2026-11-12 Dispute this row
Cormorant Asset Management, LP Partly reported under another manager2,457,521 SH82,572,706 dollarsLower by 200,000 Prior quarter: 2,657,521Open filing 0001583977-26-000011 Filed 2026-11-16 Dispute this row
Sofinnova Investments, Inc. 1,904,408 SH63,988,109 dollarsUnchanged Prior quarter: 1,904,408Open filing 0001104659-26-128032 Filed 2026-11-16 Dispute this row
JOHNSON JOHNSON Partly reported under another manager1,784,517 SH59,959,771 dollarsUnchanged Prior quarter: 1,784,517Open filing 0000904454-26-000541 Filed 2026-10-26 Dispute this row
Polar Capital Holdings Plc Partly reported under another manager1,603,582 SH53,880,355 dollarsLower by 4,932 Prior quarter: 1,608,514Open filing 0001172661-26-005169 Filed 2026-11-16 Dispute this row
VANGUARD CAPITAL MANAGEMENT LLC 1,579,991 SH53,087,698 dollarsHigher by 233,479 Prior quarter: 1,346,512Open filing 0002100119-26-001711 Filed 2026-11-13 Dispute this row
BAKER BROS. ADVISORS LP 1,547,090 SH51,982,224 dollarsUnchanged Prior quarter: 1,547,090Open filing 0001104659-26-128308 Filed 2026-11-16 Dispute this row
TRV GP VI, LLC 969,218 SH32,565,725 dollarsUnchanged Prior quarter: 969,218Open filing 0001193125-26-463547 Filed 2026-11-16 Dispute this row
STATE STREET CORP Partly reported under another manager916,471 SH30,793,426 dollarsHigher by 97,759 Prior quarter: 818,712Open filing 0000093751-26-000747 Filed 2026-11-12 Dispute this row
GEODE CAPITAL MANAGEMENT, LLC Partly reported under another manager869,740 SH29,230,030 dollarsHigher by 76,287 Prior quarter: 793,453Open filing 0001214717-26-000012 Filed 2026-11-06 Dispute this row
PERCEPTIVE ADVISORS LLC 724,342 SH24,337,891 dollarsLower by 49,000 Prior quarter: 773,342Open filing 0001012975-26-001063 Filed 2026-11-16 Dispute this row
PRICE T ROWE ASSOCIATES INC /MD/ Partly reported under another manager642,444 SH21,587 dollarsLower by 145,002 Prior quarter: 787,446Open filing 0000080255-26-000736 Filed 2026-11-16 Dispute this row
Siren, L.L.C. Partly reported under another manager641,469 SH21,553,358 dollarsUnchanged Prior quarter: 641,469Open filing 0002005245-26-000013 Filed 2026-11-12 Dispute this row
ALLIANCEBERNSTEIN L.P. Partly reported under another manager629,508 SH21,151,469 dollarsLower by 63,876 Prior quarter: 693,384Open filing 0001109448-26-000342 Filed 2026-11-16 Dispute this row
Capital World Investors Partly reported under another manager551,657 SH18,535,675 dollarsUnchanged Prior quarter: 551,657Open filing 0001422849-26-000169 Filed 2026-11-12 Dispute this row
Artisan Partners Limited Partnership 437,608 SH14,703,629 dollarsNot in the prior quarter’s filings read Open filing 0001466153-26-000009 Filed 2026-11-13 Dispute this row
DIMENSIONAL FUND ADVISORS LP Partly reported under another manager403,205 SH13,545,550 dollarsHigher by 41,091 Prior quarter: 362,114Open filing 0000354204-26-001096 Filed 2026-11-04 Dispute this row
VANGUARD PORTFOLIO MANAGEMENT LLC 362,611 SH12,183,730 dollarsHigher by 2,667 Prior quarter: 359,944Open filing 0002100121-26-001150 Filed 2026-11-13 Dispute this row
Candriam S.C.A. 346,696 SH11,691,547 dollarsLower by 954 Prior quarter: 347,650Open filing 0001537014-26-000009 Filed 2026-11-03 Dispute this row
Ikarian Capital, LLC Option: Put 316,400 SH10,631,040 dollarsNot in the prior quarter’s filings read Open filing 0001420506-26-002881 Filed 2026-11-16 Dispute this row
ALGERT GLOBAL LLC Partly reported under another manager303,720 SH10,204,992 dollarsHigher by 79,898 Prior quarter: 223,822Open filing 0001275218-26-000018 Filed 2026-11-17 Dispute this row
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 303,658 SH10,202,909 dollarsHigher by 56,843 Prior quarter: 246,815Open filing 0000884546-26-000417 Filed 2026-11-16 Dispute this row
NORTHERN TRUST CORP Partly reported under another manager295,098 SH9,915,294 dollarsHigher by 17,793 Prior quarter: 277,305Open filing 0000073124-26-000067 Filed 2026-11-16 Dispute this row
Sio Capital Management, LLC 291,231 SH9,785,362 dollarsLower by 16,426 Prior quarter: 307,657Open filing 0001214659-26-014302 Filed 2026-11-16 Dispute this row
Nuveen, LLC Partly reported under another manager267,107 SH8,974,795 dollarsHigher by 163,746 Prior quarter: 103,361Open filing 0000930413-26-003284 Filed 2026-11-10 Dispute this row
KENNEDY CAPITAL MANAGEMENT LLC 251,912 SH8,464,243 dollarsHigher by 1,117 Prior quarter: 250,795Open filing 0000884589-26-000015 Filed 2026-11-13 Dispute this row
VANGUARD FIDUCIARY TRUST CO 246,306 SH8,275,882 dollarsHigher by 37,973 Prior quarter: 208,333Open filing 0000933478-26-000017 Filed 2026-11-13 Dispute this row
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Partly reported under another manager219,740 SH7,383,265 dollarsLower by 424,342 Prior quarter: 644,082Open filing 0000861177-26-000005 Filed 2026-11-16 Dispute this row
Casdin Capital, LLC 200,000 SH6,720,000 dollarsNot in the prior quarter’s filings read Open filing 0000919574-26-008113 Filed 2026-11-16 Dispute this row
Invesco Ltd. Partly reported under another manager182,132 SH6,119,634 dollarsLower by 33,104 Prior quarter: 215,236Open filing 0000914208-26-000462 Filed 2026-11-12 Dispute this row
LORD, ABBETT CO. LLC 179,139 SH6,019 dollarsNot in the prior quarter’s filings read Open filing 0000930413-26-003314 Filed 2026-11-13 Dispute this row
Artia Global Partners LP Partly reported under another manager166,508 SH5,594,669 dollarsHigher by 28,000 Prior quarter: 138,508Open filing 0001937964-26-000011 Filed 2026-11-16 Dispute this row
Ikarian Capital, LLC Option: Call 166,400 SH5,591,040 dollarsNot in the prior quarter’s filings read Open filing 0001420506-26-002881 Filed 2026-11-16 Dispute this row
Ghisallo Capital Management LLC 150,000 SH5,040,000 dollarsNot in the prior quarter’s filings read Open filing 0001172661-26-005189 Filed 2026-11-16 Dispute this row
DAFNA Capital Management LLC 141,900 SH4,767,840 dollarsHigher by 66,900 Prior quarter: 75,000Open filing 0001389933-26-000010 Filed 2026-11-16 Dispute this row
Ensign Peak Advisors, Inc 126,780 SH4,259,808 dollarsLower by 38,766 Prior quarter: 165,546Open filing 0001454984-26-000011 Filed 2026-11-12 Dispute this row
SUSQUEHANNA INTERNATIONAL GROUP, LLP Option: Call Partly reported under another manager119,200 SH4,005,120 dollarsHigher by 110,500 Prior quarter: 8,700Open filing 0001446194-26-000009 Filed 2026-11-16 Dispute this row
Swedbank AB Partly reported under another manager117,400 SH3,944,640 dollarsUnchanged Prior quarter: 117,400Open filing 0000946431-26-000009 Filed 2026-10-27 Dispute this row
D. E. Shaw Co., Inc. Partly reported under another manager114,318 SH3,841,085 dollarsLower by 100,513 Prior quarter: 214,831Open filing 0001104659-26-128287 Filed 2026-11-16 Dispute this row
WELLINGTON MANAGEMENT GROUP LLP Partly reported under another manager109,324 SH3,673,287 dollarsHigher by 22,336 Prior quarter: 86,988Open filing 0000902219-26-000323 Filed 2026-11-16 Dispute this row
XTX Topco Ltd Partly reported under another manager102,916 SH3,457,978 dollarsHigher by 41,475 Prior quarter: 61,441Open filing 0001828301-26-000009 Filed 2026-11-16 Dispute this row
SPHERA FUNDS MANAGEMENT LTD. Option: Put Partly reported under another manager100,000 SH3,360,000 dollarsNot in the prior quarter’s filings read Open filing 0001496201-26-000006 Filed 2026-11-16 Dispute this row
SPHERA FUNDS MANAGEMENT LTD. Partly reported under another manager100,000 SH3,360,000 dollarsNot in the prior quarter’s filings read Open filing 0001496201-26-000006 Filed 2026-11-16 Dispute this row
BOOTHBAY FUND MANAGEMENT, LLC Option: Put 99,500 SH3,343,200 dollarsNot in the prior quarter’s filings read Open filing 0001549230-26-000012 Filed 2026-11-16 Dispute this row
Woodline Partners LP 98,128 SH3,297,101 dollarsHigher by 591 Prior quarter: 97,537Open filing 0001172661-26-005063 Filed 2026-11-16 Dispute this row
Managers in the prior quarter with no filing read for the latest

They may simply not have filed yet: absent from the latest quarter’s filings read is not the same as a position sold.

  • Vestal Point Capital, LP 730,000 SH
  • T. Rowe Price Investment Management, Inc. 393,200 SH
  • Burkehill Global Management, LP 250,000 SH
  • Sixth Street Partners Management Company, L.P. 246,815 SH
  • ADAGE CAPITAL PARTNERS GP, L.L.C. 150,000 SH
  • ORBIMED ADVISORS LLC 76,616 SH
  • STEMPOINT CAPITAL LP 66,582 SH
  • Allspring Global Investments Holdings, LLC 57,468 SH
  • Ellsworth Advisors, LLC 24,539 SH
  • Y-Intercept (Hong Kong) Ltd 19,189 SH
  • Sound Capital Solutions LLC 14,606 SH
  • OPTIMIZE FINANCIAL INC. 14,606 SH
  • PSP Research LLC 14,000 SH
  • Jupiter Topco LLC 13,800 SH
  • VARCOV Co. 12,895 SH
  • INTECH INVESTMENT MANAGEMENT LLC 8,371 SH
  • ProShare Advisors LLC 5,580 SH
  • Pictet Asset Management Holding SA 5,198 SH
  • MEEDER ASSET MANAGEMENT INC 2,774 SH
  • MERCER GLOBAL ADVISORS INC /ADV 519 SH
  • Integrated Wealth Concepts LLC 220 SH
  • Stone House Investment Management, LLC 211 SH
  • TD Waterhouse Canada Inc. 123 SH
  • Optiver Holding B.V. 54 SH
  • US BANCORP \DE\ 14 SH
  • NATIONAL BANK OF CANADA /FI/ 7 SH
  • Form 13F covers long positions in Section 13(f) securities only: no short positions and no securities outside that list.
  • A manager that has not yet filed for the latest quarter is absent, not at zero; filings are due up to 45 days after quarter end.
  • A change is the difference between two quarter-end snapshots, not a trade.
  • A position reported under another manager may also appear in that manager’s filing; rows are not added together.
  • Holdings the securities list cannot place with this company, or places ambiguously, are not shown.

Trades by members of Congress

Periodic transaction reports filed by U.S. House members that name this company’s stock. Dates and amounts are as filed.

No House member’s trade in this company is placed in the store. A trade not yet filed or not linked to a company is absent, not zero.

5% holders (Schedule 13D and 13G)

Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.

5% holders, newest event first, as filed
HolderPercent of classShares heldEvent dateFormSource
Cormorant Asset Management, LP Common Stock, $0.001 par value per share5.122,457,521.0009/30/2026 Filed 2026-11-16SCHEDULE 13G/AAmendment 6Open filing 0001172661-26-005299 Dispute this row
Bihua Chen Common Stock, $0.001 par value per share5.122,457,521.0009/30/2026 Filed 2026-11-16SCHEDULE 13G/AAmendment 6Open filing 0001172661-26-005299 Dispute this row
Cormorant Asset Management, LP Common Stock, $0.001 par value per share5.562,657,521.0006/30/2026 Filed 2026-08-14SCHEDULE 13G/AAmendment 5Open filing 0001172661-26-003693 Dispute this row
Bihua Chen Common Stock, $0.001 par value per share5.562,657,521.0006/30/2026 Filed 2026-08-14SCHEDULE 13G/AAmendment 5Open filing 0001172661-26-003693 Dispute this row
Third Rock Ventures V, L.P. Common Stock, $0.001 par value per share13.16,280,52506/30/2026 Filed 2026-08-14SCHEDULE 13G/AAmendment 1Open filing 0001193125-26-352285 Dispute this row
Third Rock Ventures GP V, L.P. Common Stock, $0.001 par value per share13.16,280,52506/30/2026 Filed 2026-08-14SCHEDULE 13G/AAmendment 1Open filing 0001193125-26-352285 Dispute this row
TRV GP V, LLC Common Stock, $0.001 par value per share13.16,280,52506/30/2026 Filed 2026-08-14SCHEDULE 13G/AAmendment 1Open filing 0001193125-26-352285 Dispute this row
Third Rock Ventures VI, L.P. Common Stock, $0.001 par value per share2.0969,21806/30/2026 Filed 2026-08-14SCHEDULE 13G/AAmendment 1Open filing 0001193125-26-352285 Dispute this row
Third Rock Ventures GP VI, L.P. Common Stock, $0.001 par value per share2.0969,21806/30/2026 Filed 2026-08-14SCHEDULE 13G/AAmendment 1Open filing 0001193125-26-352285 Dispute this row
TRV GP VI, LLC Common Stock, $0.001 par value per share2.0969,21806/30/2026 Filed 2026-08-14SCHEDULE 13G/AAmendment 1Open filing 0001193125-26-352285 Dispute this row
Capital International Investors Common Stock6.12,921,958.0006/30/2026 Filed 2026-08-12SCHEDULE 13G/AAmendment 1Open filing 0001562230-26-000114 Dispute this row
Cormorant Asset Management, LP Common Stock, $0.001 par value per share6.192,957,521.0003/31/2026 Filed 2026-05-15SCHEDULE 13G/AAmendment 4Open filing 0001172661-26-002222 Dispute this row
Bihua Chen Common Stock, $0.001 par value per share6.192,957,521.0003/31/2026 Filed 2026-05-15SCHEDULE 13G/AAmendment 4Open filing 0001172661-26-002222 Dispute this row
Cormorant Asset Management, LP Common Stock, $0.001 par value per share6.353,027,521.0012/31/2025 Filed 2026-02-17SCHEDULE 13G/AAmendment 3Open filing 0001172661-26-001034 Dispute this row
Bihua Chen Common Stock, $0.001 par value per share6.353,027,521.0012/31/2025 Filed 2026-02-17SCHEDULE 13G/AAmendment 3Open filing 0001172661-26-001034 Dispute this row
BlackRock, Inc. Common Stock5.032,397,54912/31/2025 Filed 2026-01-21SCHEDULE 13GOpen filing 0002012383-26-000711 Dispute this row
Cormorant Asset Management, LP Common Stock, $0.001 par value per share6.703,192,521.0009/30/2025 Filed 2025-11-14SCHEDULE 13G/AAmendment 2Open filing 0001172661-25-004952 Dispute this row
Bihua Chen Common Stock, $0.001 par value per share6.703,192,521.0009/30/2025 Filed 2025-11-14SCHEDULE 13G/AAmendment 2Open filing 0001172661-25-004952 Dispute this row
JOHNSON JOHNSON Common Stock, $0.001 par value4.91,784,517.0009/30/2025 Filed 2025-10-22SCHEDULE 13G/AAmendment 1Open filing 0000904454-25-000502 Dispute this row
Johnson Johnson Innovation - JJDC, Inc. Common Stock, $0.001 par value4.91,784,517.0009/30/2025 Filed 2025-10-22SCHEDULE 13G/AAmendment 1Open filing 0000904454-25-000502 Dispute this row
Sofinnova Venture Partners XI, L.P. ("SVP XI") Common Stock, $0.001 par value4.01,863,327.0009/11/2025 Filed 2025-09-18SCHEDULE 13D/AAmendment 1Open filing 0001104659-25-091350 Dispute this row
Sofinnova Management XI, L.P. ("SM XI LP") Common Stock, $0.001 par value4.01,863,327.0009/11/2025 Filed 2025-09-18SCHEDULE 13D/AAmendment 1Open filing 0001104659-25-091350 Dispute this row
Sofinnova Management XI, L.L.C. ("SM XI LLC") Common Stock, $0.001 par value4.01,863,327.0009/11/2025 Filed 2025-09-18SCHEDULE 13D/AAmendment 1Open filing 0001104659-25-091350 Dispute this row
Dr. James I. Healy ("Healy") Common Stock, $0.001 par value4.21,947,579.0009/11/2025 Filed 2025-09-18SCHEDULE 13D/AAmendment 1Open filing 0001104659-25-091350 Dispute this row
Dr. Maha Katabi ("Katabi") Common Stock, $0.001 par value4.01,863,327.0009/11/2025 Filed 2025-09-18SCHEDULE 13D/AAmendment 1Open filing 0001104659-25-091350 Dispute this row

Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.

What was read

2,525,707 filings read, dated 2004-06-14 to 2026-11-18: Forms 3, 3/A, 4, 4/A, 5, 5/A.

Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.

Filings read, by filing year
Filing yearFilings read
201517,857
2016222,642
2017222,009
2018223,345
2019216,482
2020166,957
2021249,835
2022216,725
2023229,674
2024234,045
2025235,520
2026262,403

Filings made before the SEC required XML are listed, not extracted.

Back to Rapport Therapeutics, Inc.